Kidney fibrosis: from mechanisms to therapeutic medicines

R Huang, P Fu, L Ma - Signal Transduction and Targeted Therapy, 2023 - nature.com
Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney
fibrosis, characterized by excessive extracellular matrix deposition leading to scarring, is a …

New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis

L Sheng, S Zhuang - Frontiers in physiology, 2020 - frontiersin.org
Epithelial-mesenchymal transition (EMT) is described as the process in which injured renal
tubular epithelial cells undergo a phenotype change, acquiring mesenchymal characteristics …

Origin and functional heterogeneity of fibroblasts

VS LeBleu, EG Neilson - The FASEB Journal, 2020 - Wiley Online Library
The inherent plasticity and resiliency of fibroblasts make this cell type a conventional tool for
basic research. But where do they come from, are all fibroblasts the same, and how do they …

Chronic kidney disease: strategies to retard progression

MT Yan, CT Chao, SH Lin - International journal of molecular sciences, 2021 - mdpi.com
Chronic kidney disease (CKD), defined as the presence of irreversible structural or
functional kidney damages, increases the risk of poor outcomes due to its association with …

microRNA crosstalk influences epithelial-to-mesenchymal, endothelial-to-mesenchymal, and macrophage-to-mesenchymal transitions in the kidney

SP Srivastava, AF Hedayat, K Kanasaki… - Frontiers in …, 2019 - frontiersin.org
microRNAs (miRNAs) are small, non-coding nucleotides that regulate diverse biological
processes. Altered microRNA biosynthesis or regulation contributes to pathological …

[HTML][HTML] MicroRNAs in kidney development and disease

DM Cerqueira, M Tayeb, J Ho - JCI insight, 2022 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) belong to a class of endogenous small noncoding RNAs that regulate
gene expression at the posttranscriptional level, through both translational repression and …

[HTML][HTML] LncRNA GAS5 exacerbates renal tubular epithelial fibrosis by acting as a competing endogenous RNA of miR-96-5p

W Wang, Y Jia, Y Yang, M Xue, Z Zheng… - Biomedicine & …, 2020 - Elsevier
Renal fibrosis is at the core of various renal diseases, including diabetic kidney disease
(DKD). Long noncoding RNAs (lncRNAs) are known players in the regulation of renal …

Cellular phenotypic transitions in diabetic nephropathy: an update

Y Cao, JH Lin, HP Hammes, C Zhang - Frontiers in Pharmacology, 2022 - frontiersin.org
Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the
most common cause of end stage renal disease (ESRD). Renal fibrosis is the final …

Target binding triggers hierarchical phosphorylation of human Argonaute-2 to promote target release

B Bibel, E Elkayam, S Silletti, EA Komives… - Elife, 2022 - elifesciences.org
Argonaute (Ago) proteins play a central role in post-transcriptional gene regulation through
RNA interference (RNAi). Agos bind small RNAs (sRNAs) including small interfering RNAs …

LCZ696 (sacubitril/valsartan) protects against cyclophosphamide-induced nephrotoxicity in adult male rats: Up-regulation of Apelin-13/ACE2, miR-200, and down …

SS Abbas, MF Schaalan, SM Gebril, FE Hassan… - Life Sciences, 2022 - Elsevier
Background Cyclophosphamide (CP) is a widely used chemotherapeutic drug. However, the
associated nephrotoxicity restricts its clinical use. Aim The present research was designed to …